Foot, Jonathan Stuart,McDonald, Ian Alexander,Deodhar, Mandar,Turner, Craig Ivan
申请号：
AU2008327615
公开号：
AU2008327615B2
申请日:
2008.11.19
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The present invention is related to the preparation and pharmaceutical use of novel haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I, as defined in the specification:(I). The invention also relates to methods of using invention compounds, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases.
